Alfa Laval signs joint marketing agreement with Millipore

7/28/2003 9:16 AM EST

Alfa Laval, a world leader in centrifugal separation, heat transfer and fluid
handling, and Millipore Corporation, a multinational bioscience company, today
announced a USA joint marketing agreement for Alfa Laval's high-speed
biotechnology centrifuges and Millipore's multi-layer Millistak+® HC depth
filters. This integration of equipment will allow the efficient recovery of
biopharmaceutical proteins generated by cell culture and fermentation.

"The first steps in drug recovery after a bioreactor are often the most
challenging and require a series of centrifugation and filtration steps. By
combining our knowledge with Millipore's we are able to offer our customers with
an optimal solution for primary recovery," says Kirk Spitzer, President of Alfa
Laval Inc. the U.S. subsidiary of the Alfa Laval Group.

Under the terms of the agreement, each company will exclusively promote the
other company's products to customers requiring centrifugation and depth
filtration. Furthermore, this partnership encompasses assistance with sales
activities, preparation and publication of technical articles, joint field-
testing and customer demonstrations of this centrifugation and depth filtration
combination.

"The expertise from both companies will speed the drug development process and
enhance customer process economics. Integrating and optimizing the key
technologies of centrifugal separation and depth filtration will improve
customers' process efficiency, lower capital costs and reduce operating costs,"
says Susan Vogt, President of Millipore's Biopharmaceutical Division.

Editor's notes:
Alfa Laval is a leading global provider of specialized products and engineering
solutions based on its key technologies of heat transfer, separation and fluid
handling.
The company's equipment, systems and services are dedicated to assisting
customers in optimizing the performance of their processes. The solutions help
them to heat, cool, separate and transport products in industries that produce
foods and beverages, chemicals and petrochemicals, pharmaceuticals, starch,
sugar and ethanol. Alfa Laval's products are also used in power plants, aboard
ships, in the mechanical engineering industry, in the mining industry and for
wastewater treatment, as well as for comfort climate and refrigeration
applications.

Alfa Laval's worldwide organization works closely with customers in nearly 100
countries to help them stay ahead in the global arena.
Alfa Laval is listed on the Stockholm Exchange and, in 2002, posted annual sales
of about SEK 15 billion (approx. 1.7 billion euros). The company has some 9,100
employees.

For further information, please visit the Alfa Laval website at
www.alfalaval.com

Millipore is a multinational bioscience company that provides technologies,
tools and service for the discovery, development and production of new
therapeutic drugs. It serves the life science, biotechnology and pharmaceutical
industries.
Millipore is listed on the New York Stock Exchange
For more information, please visit the Millipore website at www.millipore.com.


For further information please contact:
Peter Torstensson Mikael Sjöblom

Vice President, Communications Investor Relation Manager

Mobile: +46 709 33 72 31 Mobile: +46 709 78 74 82